Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines.

Peletta, Allegra; Lemoine, Céline; Courant, Thomas; Collin, Nicolas; Borchard, Gerrit

Peletta, Allegra; Lemoine, Céline; Courant, Thomas; Collin, Nicolas; Borchard, Gerrit.

Afiliación

Peletta A; Section of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Rue Michel-Servet 1, 1221 Geneva, Switzerland. Electronic address: Allegra.Peletta@unige.ch.
Lemoine C; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-les-Ouates, Switzerland. Electronic address: Celine.lemoine@vformulation.org.
Courant T; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-les-Ouates, Switzerland. Electronic address: Thomas.courant@vformulation.org.
Collin N; Vaccine Formulation Institute, Rue du Champ-Blanchod 4, 1228 Plan-les-Ouates, Switzerland. Electronic address: Nicolas.collin@vformulation.org.
Borchard G; Section of Pharmaceutical Sciences, Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), University of Geneva, Rue Michel-Servet 1, 1221 Geneva, Switzerland. Electronic address: Gerrit.Borchard@unige.ch.

Pharmacol Res ; 189: 106699, 2023 03.

Article en En | MEDLINE | ID: mdl-36796463

Asunto(s)

COVID-19; Vacunas; Humanos; Adyuvantes de Vacunas; Pandemias; Vacunación/métodos; Vacunas de Subunidad; Adyuvantes Inmunológicos

Palabras clave

Accessibility; Adjuvants; Formulation; Pandemic vaccines; Vaccines

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google